8-K: Hercules Capital Achieves Record Q2 2025 Financial Results and Declares $0.47 Distribution

Hercules Capital announced record second quarter 2025 financial results, including over $1.0 billion in new commitments and $709.1 million in fundings, alongside a $0.47 per share cash distribution.

Summary

• Total gross debt and equity commitments reached a record $1.0 billion in Q2 2025, marking a 45.7% increase year-over-year.
• Record total gross fundings of $709.1 million were achieved in Q2 2025, up 53.7% from the prior year.
• Net Investment Income (NII) for Q2 2025 was a record $88.7 million, or $0.50 per share, providing 125% coverage of the base cash distribution.
• The company declared a second quarter 2025 total cash distribution of $0.47 per share, comprising a $0.40 base distribution and a $0.07 supplemental distribution.
• Assets Under Management (AUM) increased by 16.5% year-over-year to over $5.3 billion.
• Available liquidity stood at $785.6 million at the end of Q2 2025, including $52.2 million in unrestricted cash and $733.4 million available under credit facilities.
• The Net Asset Value (NAV) per share increased by 2.5% to $11.84 as of June 30, 2025, from $11.55 in Q1 2025.
• The weighted average grade of the debt investment portfolio improved to 2.26 in Q2 2025 from 2.31 in Q1 2025, indicating improved credit quality.
• Non-accrual loans decreased, with only one debt investment on non-accrual as of June 30, 2025, representing 0.2% of the total investment portfolio at cost and fair value.
• The company closed an upsized offering of $350.0 million of 6.000% Unsecured Notes due 2030 and renewed and increased its credit facility with MUFG Bank, Ltd. to $440.0 million.
• Hercules Adviser LLC completed the first close of its fourth institutional private credit fund, now managing approximately $1.6 billion in committed debt and equity capital.

Sentiment

Score: 9

Explanation: The filing presents overwhelmingly positive financial and operational results, including multiple record achievements in commitments, fundings, and net investment income. Strong liquidity, improving credit quality, and a healthy distribution coverage further contribute to a highly positive sentiment.

Positives

• Record Q2 2025 total gross debt and equity commitments of $1.0 billion, a 45.7% increase year-over-year.
• Record Q2 2025 total gross fundings of $709.1 million, a 53.7% increase year-over-year.
• Record 1H 2025 total debt and equity commitments of $2.02 billion, a 23.0% increase year-over-year.
• Record 1H 2025 total gross fundings of $1.25 billion, a 17.0% increase year-over-year.
• Record Q2 2025 Net Investment Income (NII) of $88.7 million.
• NII of $0.50 per share provides 125% coverage of the base cash distribution.
• Over $5.3 billion of Assets Under Management, an increase of 16.5% year-over-year.
• Total Investment Income increased to $137.5 million for Q2 2025, up 10.0% year-over-year.
• Available liquidity of $785.6 million, including $52.2 million in unrestricted cash and $733.4 million available under credit facilities.
• Net Asset Value (NAV) per share increased 2.5% to $11.84 from $11.55 in Q1 2025.
• GAAP Effective Yield increased to 13.9% in Q2 2025 from 13.0% in Q1 2025.
• Core Yield of 12.5% was within the company's expected range of 12.0% to 12.5%.
• Weighted average grade of the debt investment portfolio improved to 2.26 from 2.31, indicating strong credit discipline.
• Number of loans on non-accrual decreased quarter-over-quarter, with only one debt investment on non-accrual.
• Successfully closed an upsized offering of $350.0 million of 6.000% Unsecured Notes due 2030.
• Renewed and increased its credit facility with MUFG Bank, Ltd. to $440.0 million.
• Hercules Adviser LLC completed the first close of its fourth institutional private credit fund, managing approximately $1.6 billion in committed debt and equity capital.
• Undistributed Earnings Spillover of $134.1 million, or $0.74 per ending shares outstanding.

Negatives

• Net realized losses of ($57.6) million were recorded in Q2 2025, primarily due to losses on debt and warrant investments and foreign exchange movements.
• NII per share decreased slightly to $0.50 in Q2 2025 from $0.51 in Q2 2024, primarily due to an increase in basic weighted average shares outstanding.

Risks

• Forward-looking statements are not guarantees of future performance and are subject to various risks and uncertainties that could cause actual results to differ materially from historical experience and present expectations, as discussed in the Annual Report on Form 10-K.
• Various portfolio companies will require additional rounds of funding from time to time to maintain their operations.
• The company may selectively downgrade portfolio companies if they are not meeting financing criteria or are underperforming relative to their respective business plans.
• There can be no assurances that companies that have yet to complete their IPOs will do so or that pending merger announcements will close.

Future Outlook

The company has a robust pipeline of high-quality investment opportunities, with $480.0 million in signed non-binding term sheets outstanding as of July 28, 2025. These term sheets generally convert to contractual commitments within approximately 90 days. The company continues to strengthen its balance sheet and liquidity to support its growth objectives and is well-positioned to evaluate and identify the best risk-adjusted opportunities for shareholders.

Management Comments

• "Our vibrant ecosystem and industry-leading investment team has provided a robust pipeline of high-quality investment opportunities that delivered over $1.0 billion of new debt and equity commitments for the second consecutive quarter and record fundings of over $709.0 million in Q2."
• "In the first half of 2025, we achieved records for both gross originations and fundings of $2.02 billion and $1.25 billion, respectively."
• "Our net investment income of $0.50 per share provided 125% coverage of our base distribution. Moreover, we have delivered core income in excess of $100.0 million for nine consecutive quarters, demonstrating the resilient and consistent earnings power of our platform."
• "We continue to strengthen our balance sheet and liquidity to support our growth objectives. We successfully raised a new institutional bond of $350.0 million, renewed and increased our credit facility with MUFG to $440.0 million and recently completed a first close of our Adviser Subsidiary's fourth institutional private credit fund, all of which continue to position us well to evaluate and potentially identify the best risk-adjusted opportunities for our shareholders."

Industry Context

Hercules Capital positions itself as the largest and leading specialty financing provider to innovative venture, growth, and established stage companies backed by top-tier venture capital and private equity firms. Its strong performance in commitments and fundings suggests continued demand for venture growth loans in the technology and life sciences sectors, aligning with its market leadership.

Comparison to Industry Standards

• The filing highlights Hercules Capital's position as the 'largest and leading specialty finance company' in its niche, providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies.
• No specific comparable companies, projects, or results from direct competitors were provided within the filing to benchmark against industry standards beyond the company's self-proclaimed market leadership.

Related Party Transactions

• Hercules maintains an asset management business through its wholly-owned subsidiary, Hercules Adviser LLC (the Adviser Subsidiary), which manages investments for external parties (Adviser Funds).
• Net Hercules commitments and fundings are reported net of what was assigned to or directly committed or funded by the Adviser Funds during the quarter.
• The Adviser Subsidiary completed the first close of its fourth institutional private credit fund, now managing approximately $1.6 billion in committed debt and equity capital.

Stakeholder Impact

• Shareholders: Benefit from a declared cash distribution of $0.47 per share, strong Net Investment Income coverage of the base distribution (125%), and an increase in Net Asset Value per share (2.5%).
• Employees: Employee compensation expenses increased, indicating potential benefits for the workforce.
• Customers (Portfolio Companies): The company's record commitments and fundings demonstrate continued access to growth capital for innovative venture and growth stage companies.
• Creditors: The successful upsized offering of unsecured notes and increased credit facilities strengthen the company's capital structure and ability to meet obligations.

Next Steps

• The company has scheduled its second quarter 2025 financial results conference call for July 31, 2025, at 2:00 p.m. PT (5:00 p.m. ET).
• Pending commitments from signed non-binding term sheets, totaling $480.0 million as of July 28, 2025, are expected to convert to contractual commitments in approximately 90 days from signing.

Key Dates

Recommendation

The filing demonstrates exceptional financial performance with record commitments, fundings, and Net Investment Income, indicating robust operational execution and strong market demand for its services. The 125% NII coverage of the base distribution, improving credit quality, increased liquidity, and rising Net Asset Value per share all point to a healthy and growing business. The successful capital raise further strengthens its capacity for future growth. These factors collectively suggest a strong investment opportunity.

Keywords

Venture debt, Specialty finance, Growth capital, Technology, Life sciences, BDC, Private credit, Venture capital, SEC filing, Earnings report, Financial results, Investment income, Net Investment Income, Dividends, Liquidity, Asset management